Prognostic value of in-hospital change in cystatin C in patients with acutely decompensated heart failure and renal dysfunction
- 1 March 2015
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 182, 74-76
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Inotropes for the management of acute heart failure patients with renal dysfunction. Still an option?Expert Opinion on Pharmacotherapy, 2012
- Natriuretic Peptide Testing for Predicting Adverse Events Following Heart Failure HospitalizationCongestive Heart Failure, 2012
- Cystatin C as a Marker of Glomerular Filtration Rate in Voluntary Kidney DonorsExperimental and Clinical Transplantation, 2012
- Prognostic factors of mid-term clinical outcome in congestive heart failure patients discharged after acute decompensationArchives of Medical Science, 2012
- Cystatin C, NT-proBNP, and inflammatory markers in acute heart failure: insights into the cardiorenal syndromeBiomarkers, 2011
- Markers of renal function and acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardiorenal syndromeEuropean Heart Journal, 2010
- Cystatin C and NT-proBNP, A Powerful Combination of Biomarkers for Predicting Cardiovascular Mortality in Elderly Patients with Heart Failure: Results from a 10-Year Study in Primary CareEuropean Journal of Heart Failure, 2009
- Cardiorenal SyndromeJACC, 2008
- Worsening Renal Function and Prognosis in Heart Failure: Systematic Review and Meta-AnalysisJournal of Cardiac Failure, 2007
- Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNPEuropean Heart Journal, 2007